Myocarditis following COVID-19 mRNA vaccination

SA Mouch, A Roguin, E Hellou, A Ishai, U Shoshan… - vaccine, 2021 - Elsevier
Background Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety. We report
six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. Methods …
被引用次数：303 相关文章

Myocarditis following COVID-19 mRNA vaccination.

A Mouch, A Roguin, E Hellou, A Ishai, U Shoshan… - Vaccine, 2021 - europepmc.org
Background Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety. We report
six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. Methods …
[PDF] health.gov.il

[PDF][PDF] Myocarditis following COVID-19 mRNA vaccination

SA Mouch, A Roguin, E Hellou, A Ishai, U Shoshan… - vaccine, 2021 - hy.health.gov.il
abstract Background: Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety.
We report six cases of myocarditis, which occurred shortly after BNT162b2 vaccination …
[PDF] hymc.org.il

[PDF][PDF] Myocarditis following COVID-19 mRNA vaccination

SA Mouch, A Roguin, E Hellou, A Ishai, U Shoshan… - vaccine, 2021 - hymc.org.il
abstract Background: Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety.
We report six cases of myocarditis, which occurred shortly after BNT162b2 vaccination …

Myocarditis following COVID-19 mRNA vaccination

SA Mouch, A Roguin, E Hellou, A Ishai… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety. We report
six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. Methods …

[引用][C] Myocarditis following COVID-19 mRNA vaccination

SA Mouch, A Roguin, E Hellou, A Ishai, U Shoshan… - Vaccine, 2021 - cir.nii.ac.jp

Myocarditis following COVID-19 mRNA vaccination.

S Abu Mouch, A Roguin, E Hellou, A Ishai, U Shoshan… - 2021 - cabidigitallibrary.org
Background Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety. We report
six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. Methods …
[HTML] nih.gov

[HTML][HTML] Myocarditis following COVID-19 mRNA vaccination

SA Mouch, A Roguin, E Hellou, A Ishai, U Shoshan… - Vaccine, 2021 - ncbi.nlm.nih.gov
Background Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety. We report
six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. Methods …
[PDF] academia.edu

[PDF][PDF] Myocarditis following COVID-19 mRNA vaccination

SA Mouch, A Roguin, E Hellou, A Ishai, U Shoshan… - vaccine, 2021 - academia.edu
abstract Background: Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety.
We report six cases of myocarditis, which occurred shortly after BNT162b2 vaccination …

Myocarditis following COVID-19 mRNA vaccination.

A Mouch, A Roguin, E Hellou, A Ishai, U Shoshan… - Vaccine, 2021 - europepmc.org
Background Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety. We report
six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. Methods …